Language: English
Jointly organised by the Faculty of Medicine, The Chinese University of Hong Kong and the Chinese Manufacturers' Association of Hong Kong, Hong Kong Global Cancer IP Investors Forum 2025 aims to provide an effective platform for biomedical R&D entrepreneurs, investors, pharmaceutical multinationals, scholars, and professional service providers for intellectual property (IP) transactions, licensing, investment, and financing.
For event programme and details, please click here.
